Stocklytics Platform
Asset logo for symbol HOTH
Hoth Therapeutics
HOTH55
$0.81arrow_drop_up5.20%$0.04
Penny Stock
Asset logo for symbol HOTH
HOTH55

$0.81

arrow_drop_up5.20%

Performance History

Chart placeholder
Key Stats
Open$0.75
Prev. Close$0.76
EPS-1.27
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$5.59M
PE Ratio-
LOWHIGH
Day Range0.73
0.81
52 Week Range0.58
1.73
Ratios
Revenue-
EBITDA Margin %-
EPS-1.27

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Hoth Therapeutics (HOTH)

Hoth Therapeutics Inc (HOTH) is a biopharmaceutical company focused on developing therapies for patients with dermatological conditions. The company is dedicated to improving the quality of life for these patients by providing innovative treatments. HOTH is committed to addressing unmet needs in the medical community and delivering safe and effective therapies. The company believes that its pipeline of products has the potential to revolutionize the treatment of various dermatological conditions.
With a strong emphasis on research and development, Hoth Therapeutics is actively exploring novel approaches to therapy. The company is harnessing the power of the human immune system to develop targeted therapies for skin disorders. By understanding the underlying mechanisms of these conditions, HOTH aims to develop therapies that provide long-lasting relief and improved outcomes for patients.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Robb Knie
Headquarters
New York
Employees
2
Exchange
NASDAQ
add Hoth Therapeutics  to watchlist

Keep an eye on Hoth Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Hoth Therapeutics 's (HOTH) price per share?

The current price per share for Hoth Therapeutics (HOTH) is $0.81. The stock has seen a price change of $0.04 recently, indicating a 5.21% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Hoth Therapeutics (HOTH)?

For Hoth Therapeutics (HOTH), the 52-week high is $1.73, which is 113.58% from the current price. The 52-week low is $0.58, the current price is 39.66% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Hoth Therapeutics (HOTH) a growth stock?

Hoth Therapeutics (HOTH) has shown an average price growth of -4.38% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Hoth Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Hoth Therapeutics (HOTH) stock price performance year to date (YTD)?

As of the latest data, Hoth Therapeutics (HOTH) has a year-to-date price change of -44.14%. Over the past month, the stock has experienced a price change of -2.01%. Over the last three months, the change has been -16.49%. Over the past six months, the figure is -12.9%. Looking at a longer horizon, the five-year price change stands at -99.4%.
help

Is Hoth Therapeutics (HOTH) a profitable company?

Hoth Therapeutics (HOTH) has a net income of -$7.85M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$7.69M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Hoth Therapeutics (HOTH)?

Hoth Therapeutics (HOTH) has a market capitalization of $5.59M. The average daily trading volume is 0.75, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level